Patent Assignment
Reel/Frame 063169/0203
Corrective Assignment to Correct the Receiving Party Name Previously Recorded at Reel: 063065 Frame: 0689. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-03-27
Pages: 5
Assignor
ASTRAZENECA CANADA INC.
Executed: 2011-05-17
Assignee
ASTRAZENECA AB
SE-151 85, SÖDERTÄLJE, SWEDEN
Covered Property
(1)
Imidazopyridine Compounds and Uses Thereof
Application:
18/160,167 →
Publication:
US 2023/0406851
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Mar 22, 2023
From: BUON, CHRISTOPHE; CANTIN, LOUIS-DAVID; HU, YUN-JIN; LUO, XUEHONG
To: ASTRAZENECA CANADA INC.
Reel/Frame 063065/0613 →
Assignment of Assignor's Interest
Mar 22, 2023
From: AZTRAZENECA CANADA INC.
To: ASTRAZENECA AB
Reel/Frame 063065/0689 →
Assignment of Assignor's Interest
Mar 22, 2023
From: ASTRAZENECA AB
To: NEOMED INSTITUTE
Reel/Frame 063065/0757 →
Assignment of Assignor's Interest
Aug 9, 2023
From: NEOMED INSTITUTE
To: BELLUS HEALTH COUGH INC.
Reel/Frame 064530/0687 →
Merger
Aug 9, 2023
From: BELLUS HEALTH COUGH INC.
To: BELLUS HEALTH INC.
Reel/Frame 064531/0830 →
Assignment of Assignor's Interest
Aug 9, 2023
From: BELLUS HEALTH INC.
To: 14245563 CANADA INC.
Reel/Frame 065117/0909 →
Assignment of Assignor's Interest
Jan 19, 2024
From: 14245563 CANADA INC.
To: ID BIOMEDICAL CORPORATION OF QUEBEC
Reel/Frame 066353/0331 →
Assignment of Assignor's Interest
Jan 19, 2024
From: ID BIOMEDICAL CORPORATION OF QUEBEC
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY (NO.3) LIMITED
Reel/Frame 066353/0356 →